This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by WALDHÄUSL, W. Articles by NOWOTNY, P. Search for Related Content PubMed PubMed Citation Articles by WALDHÄUSL, W. Articles by NOWOTNY, P.

Prolonged Administration of Human Atrial Natriuretic Peptide in Healthy Men: Evanescent Effects on Diuresis and Natriuresis

Division of Clinical Endocrinology and Diabetes Mellitus, I. Medizinische Universitätsklinik Wien, Austria

Address all correspondence and requests for reprints to: W. Waldhäusl, M.D., Division of Clinical Endocrinology and Diabetes mellitus, I. Medizinische Universitätsklinik, Lazarettgasse 14, A-1090 Wien, Austria.

Synthetic human atrial natriuretic peptide (hANP) was administered to six normal sodium- and fluidreplete men A) as an iv bolus dose of 25 µg followed by an infusion of 25 µg/h for 6 h; B) as an iv bolus dose of 175 µg; C) as an iv bolus dose of 175 µg followed by an infusion of 100 µg/ h for 6 h; or D) as a continuous infusion of 100 µg/h for 6 h plus an iv bolus dose at 240 min. Although urinary flow rates and excretion rates of sodium and chloride increased during protocols B, C, and D, this effect either disappeared (protocol B) or waned (protocols C and D) at the end of the 6-h infusion period. A consistent decrease in blood pressure occurred only during protocols C and D. Serum concentrations of Na⁺, K⁺, and Cl^– and plasma renih concentrations did not change, while plasma aldosterone concentrations declined after the administration of 175 µg hANP or more. These data confirm that hANP exerts a diuretic and natriuretic action in man. These effects are transient and are not maintained by prolonged continuous hANP administration.

Received August 20, 1985.

This article has been cited by other articles:

				W. Wang, C. Li, L. N. Nejsum, H. Li, S. W. Kim, T.-H. Kwon, T. E. N. Jonassen, M. A. Knepper, K. Thomsen, J. Frokiaer, et al. Biphasic effects of ANP infusion in conscious, euvolumic rats: roles of AQP2 and ENaC trafficking Am J Physiol Renal Physiol, February 1, 2006; 290(2): F530 - F541. [Abstract] [Full Text] [PDF]

				A. M. Richards, P. Dessi-Fulgheri, R. Sarzani, M. Serenelli, P. Tamburrini, D. Spagnolo, L. Giantomassi, E. Espinosa, and A. Rappelli ANP Bioactivity in Obese Hypertensives • Response Hypertension, December 1, 1999; 34 (6): e16 - e17. [Full Text] [PDF]

				P. Dessi-Fulgheri, R. Sarzani, M. Serenelli, P. Tamburrini, D. Spagnolo, L. Giantomassi, E. Espinosa, and A. Rappelli Low Calorie Diet Enhances Renal, Hemodynamic, and Humoral Effects of Exogenous Atrial Natriuretic Peptide in Obese Hypertensives Hypertension, February 1, 1999; 33(2): 658 - 662. [Abstract] [Full Text] [PDF]